A Novel Method to Value Real Options in Health Care: The Case of a Multicohort Human Papillomavirus Vaccination Strategy

Abstract

Background: A large number of economic evaluations have already confirmed the cost-effectiveness of different human papillomavirus (HPV) vaccination strategies. Standard analyses might not capture the full economic value of novel vaccination programs because the cost-effectiveness paradigm fails to take into account the value of active management. Management decisions can be seen as real options, a term used to refer to the application of option pricing theory to the valuation of investments in nonfinancial assets in which much of the value is attributable to flexibility and learning over time.Objective: The aim of this article was to discuss the potential advantages shown by using the payoff method in the valuation of the cost-effectiveness of competing HPV immunization programs.Methods: This was the first study, to the best of our knowledge, to use the payoff method to determine the real option values of 4 different HPV vaccination strategies targeting female subjects aged 12, 15, 18, and 25 years. The payoff method derives the real option value from the triangular payoff distribution of the project's net present value, which is treated as a triangular fuzzy number. To inform the real option model, cost-effectiveness data were derived from an empirically calibrated Bayesian model designed to assess the cost-effectiveness of a multicohort HPV vaccination strategy in the context of the current cervical cancer screening program in Italy. A net health benefit approach was used to calculate the expected fuzzy net present value for each of the 4 vaccination strategies evaluated.Results: Costs per quality-adjusted life-year gained seemed to be related to the number of cohorts targeted: a single cohort of girls aged 12 years (€10,955 [95% CI, -1,021 to 28,212]) revealed the lowest cost among the 4 alternative strategies evaluated. The real option valuation challenged the costeffectiveness dominance of a single cohort of 12-yearold girls. The simultaneous vaccination of 2 cohorts of girls aged 12 and 15 years yielded a real option value (€17,723) equivalent to that attributed to a single cohort of 12-year-old girls (€17,460).Conclusions: The payoff method showed distinctive advantages in the valuation of the cost-effectiveness of competing health care interventions, essentially determined by the replacement of the nonfuzzy numbers that are commonly used in cost-effectiveness analysis models, with fuzzy numbers as an input to inform the real option pricing method. The real option approach to value uncertainty makes policy making in health care an evolutionary process and creates a new "space" for decision-making choices. (Clin Ther.

Economic burden of HPV9-related diseases: a real-world cost analysis from Italy

“…Genital HPV infections are contracted through unprotected vaginal or anal sexual intercourse and skin-to-skin genital contact. HPV infections that result in oral or upper respiratory malignancies are mostly contracted through unprotected oral sex [3]. Most HPV infections are asymptomatic and resolve within a few months of exposure.…”

Hospital Investment Decisions in Healthcare 4.0 Technologies: Scoping Review and Framework for Exploring Challenges, Trends, and Research Directions

“…Such valuation methodologies incorporate the value of future new information in the current analyses. The articles in the portfolio report real-options applications in proton therapy adoption analysis [ 44 , 45 ] and help formulate better human papillomavirus vaccination strategies [ 47 ]. Surprisingly, none of the articles using real-options analysis incorporated uncertainty correlations among the bundles of technologies.…”

Evolution of studies on Real Options Theory in health sector

“…This term was not found in the traditional literature of real option, however face discuss present by the author this terms seems more appropriated. Favato et al (2013) applied the payoff method to determine the real option values of four different HPV vaccination strategies. Accordint to authors, the payoff method presented distinctive advantages in the valuation of the costeffectiveness of competing health care interventions.…”

“…In 2011 Sengupta and Kreier (2011) It was in 2013 the year with the most research about ROT in health. Favato, Baio, Capone, Marcellusi and Mennini (2013) discuss the potential advantages demonstrated by using the payoff method to evaluate the cost-effectiveness of competing HPV immunization programs. Wernz, Gehrke and Ball (2013) presented the application of Real Options analysis Milena de Cássia Rocha, Márcio Augusto Gonçalves, Yuri Lawryshyn to a managerial decision-making problem.…”